Dupilumab-Induced Bilateral Cicatricial Ectropion in Real Life
- 1 February 2020
- journal article
- editorial
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (2) , 728-729
Abstract
No abstract availableFunding Information
- Mary Victoria Pragnell
This publication has 6 references indexed in Scilit:
- Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic DermatitisJAMA Dermatology, 2018
- Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab–clinical characteristics and treatmentThe Journal of Allergy and Clinical Immunology: In Practice, 2018
- Dupilumab: A Review in Moderate-to-Severe Atopic DermatitisAmerican Journal of Clinical Dermatology, 2018
- Dupilumab: short‐term effectiveness and security in real clinical practice – A retrospective multicentric studyJournal of the European Academy of Dermatology and Venereology, 2018
- Cicatricial ectropion in a patient treated with dupilumabAmerican Journal of Ophthalmology Case Reports, 2017
- Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitisJournal of the American Academy of Dermatology, 2017